PUBLISHER: The Business Research Company | PRODUCT CODE: 2127591
PUBLISHER: The Business Research Company | PRODUCT CODE: 2127591
A ribonucleic acid (RNA) isolation and enrichment products are laboratory-based products designed to extract, purify, and concentrate RNA from biological samples for molecular analysis and research purposes. These products facilitate the isolation of high-quality RNA by eliminating contaminants such as proteins, DNA, and other cellular components. They enable reliable downstream applications, including gene expression analysis, sequencing, and diagnostic testing.
The primary product types of ribonucleic acid (RNA) isolation and enrichment products include total ribonucleic acid isolation kits, messenger ribonucleic acid enrichment kits, small ribonucleic acid isolation kits, and ribonucleic acid enrichment reagents. Total ribonucleic acid isolation kits refer to products designed to extract complete RNA content from biological samples for molecular analysis and research applications. These products are designed for sample types including tissue samples, blood samples, cell samples, microorganism samples, and other biological samples, and support workflows such as manual ribonucleic acid isolation and enrichment, semi-automated ribonucleic acid isolation and enrichment, and fully automated ribonucleic acid isolation and enrichment. They are used in applications such as gene expression analysis, next-generation sequencing, drug discovery and development, biomarker discovery, and clinical diagnostics, serving end-users including universities and research laboratories.
Tariffs are influencing the ribonucleic acid (RNA) isolation and enrichment products market by increasing the cost of imported reagents, kits, and automated extraction systems used in molecular biology workflows. This is disrupting supply chains and increasing operational costs for research laboratories and diagnostic centers, especially in import-dependent regions such as Asia-Pacific and Latin America. Kit-based and automated workflow segments are experiencing the highest impact because of their reliance on specialized global manufacturing and precision components. However, tariffs are driving localized manufacturing of RNA extraction kits, supplier diversification, and increased investment in domestic life sciences infrastructure, strengthening long-term market resilience.
The ribonucleic acid (rna) isolation and enrichment products market research report is one of a series of new reports from The Business Research Company that provides ribonucleic acid (rna) isolation and enrichment products market statistics, including ribonucleic acid (rna) isolation and enrichment products industry global market size, regional shares, competitors with a ribonucleic acid (rna) isolation and enrichment products market share, detailed ribonucleic acid (rna) isolation and enrichment products market segments, market trends and opportunities, and any further data you may need to thrive in the ribonucleic acid (rna) isolation and enrichment products industry. This ribonucleic acid (rna) isolation and enrichment products market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The ribonucleic acid (RNA) isolation and enrichment products market size has grown rapidly in recent years. It will grow from $6.35 billion in 2025 to $7.05 billion in 2026 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to growing adoption of molecular biology techniques in research laboratories, expansion of genomic and transcriptomic research activities, increasing funding for life sciences and biotechnology research, early development of column based rna extraction methods, rising demand for accurate gene expression analysis tools.
The ribonucleic acid (RNA) isolation and enrichment products market size is expected to see rapid growth in the next few years. It will grow to $10.54 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to rising demand for precision medicine and personalized diagnostics, increasing adoption of next generation sequencing technologies, growth in single cell and spatial transcriptomics research, expansion of automated laboratory workflows and robotics integration, increasing investment in advanced biomarker discovery platforms. Major trends in the forecast period include increasing adoption of automated rna extraction platforms integrated with laboratory robotics, rising demand for high purity rna isolation kits for next generation sequencing workflows, growing use of magnetic bead based rna purification technologies for improved yield and efficiency, expansion of low input and single cell rna isolation solutions for advanced genomics research, increasing integration of rna isolation workflows in high throughput drug discovery and biomarker identification.
The rising genomics research activities are expected to propel the growth of the ribonucleic acid (RNA) isolation and enrichment products market going forward. Genomics research activities involve the study of genes, RNA sequencing, and molecular interactions to better understand disease biology, genetic variations, and therapeutic responses. These research activities are increasing due to the growing demand for precision medicine, which emphasizes the development of personalized treatments based on an individual's genetic profile. RNA isolation and enrichment products support genomics research by facilitating the extraction and purification of high-quality RNA for sequencing, transcriptomics, and gene expression analysis, thereby enhancing data accuracy and the reliability of downstream molecular studies. For instance, in July 2023, according to a report published by the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, at the end of the first quarter (Q1) 2023, there were 247 gene therapies in Phase II, but this number rose by 5% to reach 260 by the end of the second quarter (Q2), reflecting growing genomics and genetic research activities. Therefore, the rising genomics research activities are driving the growth of the ribonucleic acid (RNA) isolation and enrichment products market.
Major companies operating in the ribonucleic acid (RNA) isolation and enrichment products market are concentrating on developing automated RNA purification technologies, including magnetic bead-based automated extraction systems, to enhance workflow efficiency, minimize manual handling errors, and support high-throughput nucleic acid processing in clinical and research laboratories. Magnetic bead-based automated extraction systems are laboratory instruments that utilize magnetic particles to isolate and purify nucleic acids from biological samples through automated processing workflows. For instance, in January 2023, QIAGEN N.V., a Netherlands-based biotechnology company, launched the EZ2 Connect MDx platform to improve automated nucleic acid extraction and purification efficiency in diagnostic laboratories through streamlined sample processing and high-quality RNA and DNA isolation workflows. The EZ2 Connect MDx platform offers fully automated magnetic bead-based nucleic acid extraction with integrated touchscreen functionality and preloaded protocols to simplify laboratory workflows.
In January 2023, ALS Limited, an Australia-based testing laboratory company, acquired Invitek Molecular GmbH for an undisclosed amount. Through this acquisition, ALS Limited intended to enhance its molecular diagnostics and life sciences capabilities, broaden its portfolio of sample preparation and nucleic acid extraction technologies, and strengthen its presence in the global biotechnology and clinical testing markets. Invitek Molecular GmbH is a Germany-based provider of nucleic acid isolation kits, molecular diagnostic reagents, sample preparation technologies, and automated purification solutions for research, clinical, and industrial applications.
Major companies operating in the ribonucleic acid (RNA) isolation and enrichment products market report are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies Inc., Cytiva, Sartorius AG, Bio-Rad Laboratories Inc., QIAGEN N.V., Promega Corporation, Takara Bio Inc., MP Biomedicals LLC, Analytik Jena GmbH+Co. KG, Macherey-Nagel GmbH & Co. KG, New England Biolabs Inc., Zymo Research Corporation, Bioneer Corporation, Yeasen Biotechnology (Shanghai) Co. Ltd., TianGen Biotech (Beijing) Co. Ltd., Geneaid Biotech Ltd., HiMedia Laboratories Pvt. Ltd., Norgen Biotek Corp., Vazyme Biotech Co. Ltd., Illumina Inc., Pacific Biosciences of California Inc., 10x Genomics Inc., Revvity Inc., LGC Biosearch Technologies
North America was the dominating region in the ribonucleic acid (RNA) isolation and enrichment products market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the ribonucleic acid (RNA) isolation and enrichment products market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the ribonucleic acid (RNA) isolation and enrichment products market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The ribonucleic acid (RNA) isolation and enrichment products market consists of sales of ribonucleic acid (RNA) extraction kits, ribonucleic acid (RNA) purification reagents, magnetic bead-based ribonucleic acid (RNA) isolation systems, spin column ribonucleic acid (RNA) purification kits, and automated ribonucleic acid (RNA) extraction instruments. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Ribonucleic Acid (RNA) Isolation And Enrichment Products Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses ribonucleic acid (rna) isolation and enrichment products market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for ribonucleic acid (rna) isolation and enrichment products ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The ribonucleic acid (rna) isolation and enrichment products market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.